EMCURE — Emcure Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Emcure Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,084	4,468	5,174	2,407	2,163
Net Total Accounts Receivable
Net Total Receivables	15,157	19,024	21,133	22,881	25,627
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	34,241	38,359	42,599	45,559	56,121
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,855	22,148	23,972	24,271	24,908
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	60,635	66,725	78,062	82,327	96,125
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	29,648	30,192	32,105	26,683	39,122
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	40,759	41,714	48,539	37,865	46,624
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	19,875	25,011	29,523	44,462	49,500
Total Liabilities & Shareholders' Equity	60,635	66,725	78,062	82,327	96,125
Total Common Shares Outstanding